Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I F Casson

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|May 10, 2006
Pregnancy in women with diabetes--after the CEMACH report, what now?I F Casson
International Journal of Clinical Practice|June 1, 1997
Henoch-Schonlein purpura associated with ranitidineC Prajapati, I F Casson
British Journal of Diseases of the Chest|April 1, 1980
Fibrinogen degradation products in pleural effusionsO G Raja, I F Casson
Diabetic Medicine : a Journal of the British Diabetic Association|July 5, 2001
Glycated haemoglobin assays. Approaches to standardization of resultsA Stott, I F Casson, G J Higgins
Experimental and Clinical Endocrinology|April 1, 1987
A factor in the serum of diabetic patients inhibits microtubule formationI F Casson, S J Beahon, W G McLean
The British Journal of Clinical Practice|September 1, 1990
Thyrotoxicosis in a patient with Addison's diseaseI F Casson, B A Walker, L J Hipkin
Journal of Medical Genetics|March 1, 1990
Identical twins discordant for Kallmann's syndromeL J Hipkin, I F Casson, J C Davis
Neurochemical Pathology|June 1, 1986
Diabetic rat serum has an increased capacity to inhibit brain microtubule formation in vitroW G McLean, S J Beahon, I F Casson
QJM : Monthly Journal of the Association of Physicians|July 4, 2009
Nocturnal hypoglycaemia in type 1 diabetes--frequency and predictive factorsA Woodward, P Weston, I F Casson, et al.
Molecular Neurobiology|January 1, 1992
Posttranslational modifications of nerve cytoskeletal proteins in experimental diabetesW G McLean, C Pekiner, N A Cullum, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Diabetic Medicine : a Journal of the British Diabetic Association|May 10, 2006
Pregnancy in women with diabetes--after the CEMACH report, what now?I F Casson
International Journal of Clinical Practice|June 1, 1997
Henoch-Schonlein purpura associated with ranitidineC Prajapati, I F Casson
British Journal of Diseases of the Chest|April 1, 1980
Fibrinogen degradation products in pleural effusionsO G Raja, I F Casson
Diabetic Medicine : a Journal of the British Diabetic Association|July 5, 2001
Glycated haemoglobin assays. Approaches to standardization of resultsA Stott, I F Casson, G J Higgins
Experimental and Clinical Endocrinology|April 1, 1987
A factor in the serum of diabetic patients inhibits microtubule formationI F Casson, S J Beahon, W G McLean
The British Journal of Clinical Practice|September 1, 1990
Thyrotoxicosis in a patient with Addison's diseaseI F Casson, B A Walker, L J Hipkin
Journal of Medical Genetics|March 1, 1990
Identical twins discordant for Kallmann's syndromeL J Hipkin, I F Casson, J C Davis
Neurochemical Pathology|June 1, 1986
Diabetic rat serum has an increased capacity to inhibit brain microtubule formation in vitroW G McLean, S J Beahon, I F Casson
QJM : Monthly Journal of the Association of Physicians|July 4, 2009
Nocturnal hypoglycaemia in type 1 diabetes--frequency and predictive factorsA Woodward, P Weston, I F Casson, et al.
Molecular Neurobiology|January 1, 1992
Posttranslational modifications of nerve cytoskeletal proteins in experimental diabetesW G McLean, C Pekiner, N A Cullum, et al.
Pageof 3